Sanofi’s Insulin Aspart Biosimilar Gets European Nod

As Accord’s Cabazitaxel And Fingolimod Are Endorsed By CHMP

 
• By David Wallace
Insulin
Sanofi’s insulin aspart received a positive CHMP opinion • Source: Shutterstock

More from Biosimilars

More from Products